Method for selectively inhibiting ACAT1 in the treatment of alzheimer's disease

作者: Elena Bryleva , Yohei Shibuya , Ta-Yuan Chang , Maximillian A. Rogers , Catherine C. Y. Chang

DOI:

关键词:

摘要: The present invention features methods for stimulating clearance of amyloid beta in microglia, decreasing cognitive decline associated with pathology, and treating Alzheimer's disease by selectively inhibiting the expression or activity Acyl-CoA:Cholesterol Acyltransferase 1, but not 2.

参考文章(34)
Samira Lakhal-Littleton, Matthew Wood, Exosomes for Delivery of Biotherapeutics ,(2012)
Elena Bryleva, Ta-Yuan Chang, Maximillian A. Rogers, Catherine C.Y. Chang, Stephanie Murphy, Method for selectively inhibiting the activity of acat1 in the treatment of alzheimer's disease ,(2013)
Kim Ornvold, Stephen C. Strom, André Delhon, Jean-François Patoiseau, Randeep Kashyap, Ellen T. Chang, Ta Yuan Chang, Robert V. Farese, Catherine C.Y. Chang, John J. Fung, Ruhong Dong, Song Lin, Chi-Yu Gregory Lee, Naomi Sakashita, Oneil Lee, Immunological Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and Small Intestine Journal of Biological Chemistry. ,vol. 275, pp. 28083- 28092 ,(2000) , 10.1074/JBC.M003927200
Luigi Puglielli, Rudolph Tanzi, Matthew Frosch, Dora Kovacs, Methods for treating ACAT-related diseases ,(2004)
Traian V Chirila, Piroska E Rakoczy, Kerryn L Garrett, Xia Lou, Ian J Constable, The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides. Biomaterials. ,vol. 23, pp. 321- 342 ,(2002) , 10.1016/S0142-9612(01)00125-9
Alessio Peracchi, Prospects for antiviral ribozymes and deoxyribozymes. Reviews in Medical Virology. ,vol. 14, pp. 47- 64 ,(2004) , 10.1002/RMV.415
M. Giovannoni, V. Piaz, C. Vergelli, D. Barlocco, Selective ACAT Inhibitors as Promising Antihyperlipidemic, Antiatherosclerotic and Anti-Alzheimer Drugs Mini-reviews in Medicinal Chemistry. ,vol. 3, pp. 576- 584 ,(2003) , 10.2174/1389557033487890